What About Insurance?

More and more genetic tests are being developed to determine people's risk for disease, but as NPR's Michelle Andrews reports at the Shots blog, don't expect insurance companies to pay for all of the tests. Insurers, she says, typically only cover a test if there is strong evidence that there's a health benefit.

"You don't test for testing's sake," Susan Pisano, a spokesperson for the trade group America's Health Insurance Plans, tells Andrews.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.